Overview
- 2 inspections across 2 sites are on record.
- 2 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2018-11-14.
At a glance
Inspections
2
Sites
2
Observations
2
Career since
Aug 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc | 14 Nov 2018 | Human Drugs | |
| Genzyme Corporation | 10 Aug 2016 | Human Drugs |
Sites inspected
Otsuka Pharmaceutical Development & Commercialization, IncRockville, United States1 insp.
Genzyme CorporationCambridge, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
John Dan1 shared
John P Mistler1 shared
Full investigator report
Get the verbatim findings behind Danielle Pearson's 2 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site